Merck (NYSE:MRK) has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for ...
The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine [21-valent]) intended to ...
Drug major Merck & Co. (MRK) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or ...
Merck on Friday said the recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use covers the 21-valent conjugate vaccine for immunization for the prevention ...
Merck , known as MSD outside of the United States and Canada, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the ...
Merck (MRK) announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, recommended ...
Merck Receives Positive EU CHMP Opinion for CAPVAXIVEâ„¢ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal ...
Pregnant patients in their third trimester and postpartum women showed higher risk for IPD compared with nonpregnant patients.
Community-acquired pneumonia (CAP) is a systemic disease and continues to be the leading cause of infectious mortality ...
Antibiotics can be used to treat a litany of illnesses, but one thing they can’t combat is a viral infection.
While children under five, particularly those under two, are the most vulnerable, pneumococcal diseases also affect adults.
The CDC revised its pneumococcal pneumonia shot recommendation, saying there is a substantial increase in the risk for ...